Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

710 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biological significance of the CpG island methylator phenotype.
Suzuki H, Yamamoto E, Maruyama R, Niinuma T, Kai M. Suzuki H, et al. Among authors: maruyama r. Biochem Biophys Res Commun. 2014 Dec 5;455(1-2):35-42. doi: 10.1016/j.bbrc.2014.07.007. Epub 2014 Jul 10. Biochem Biophys Res Commun. 2014. PMID: 25016183 Review.
Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines.
Terasawa K, Toyota M, Sagae S, Ogi K, Suzuki H, Sonoda T, Akino K, Maruyama R, Nishikawa N, Imai K, Shinomura Y, Saito T, Tokino T. Terasawa K, et al. Among authors: maruyama r. Br J Cancer. 2006 Mar 27;94(6):914-21. doi: 10.1038/sj.bjc.6602984. Br J Cancer. 2006. PMID: 16479257 Free PMC article.
Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer.
Akino K, Toyota M, Suzuki H, Imai T, Maruyama R, Kusano M, Nishikawa N, Watanabe Y, Sasaki Y, Abe T, Yamamoto E, Tarasawa I, Sonoda T, Mori M, Imai K, Shinomura Y, Tokino T. Akino K, et al. Among authors: maruyama r. Cancer Sci. 2007 Jan;98(1):88-95. doi: 10.1111/j.1349-7006.2006.00351.x. Cancer Sci. 2007. PMID: 17083569 Free article.
PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer.
Watanabe Y, Toyota M, Kondo Y, Suzuki H, Imai T, Ohe-Toyota M, Maruyama R, Nojima M, Sasaki Y, Sekido Y, Hiratsuka H, Shinomura Y, Imai K, Itoh F, Tokino T. Watanabe Y, et al. Among authors: maruyama r. Clin Cancer Res. 2007 Aug 15;13(16):4786-94. doi: 10.1158/1078-0432.CCR-07-0305. Clin Cancer Res. 2007. PMID: 17699856
Gene amplification and overexpression of PRDM14 in breast cancers.
Nishikawa N, Toyota M, Suzuki H, Honma T, Fujikane T, Ohmura T, Nishidate T, Ohe-Toyota M, Maruyama R, Sonoda T, Sasaki Y, Urano T, Imai K, Hirata K, Tokino T. Nishikawa N, et al. Among authors: maruyama r. Cancer Res. 2007 Oct 15;67(20):9649-57. doi: 10.1158/0008-5472.CAN-06-4111. Cancer Res. 2007. PMID: 17942894
Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma.
Imai T, Toyota M, Suzuki H, Akino K, Ogi K, Sogabe Y, Kashima L, Maruyama R, Nojima M, Mita H, Sasaki Y, Itoh F, Imai K, Shinomura Y, Hiratsuka H, Tokino T. Imai T, et al. Among authors: maruyama r. Cancer Sci. 2008 May;99(5):958-66. doi: 10.1111/j.1349-7006.2008.00769.x. Epub 2008 Feb 24. Cancer Sci. 2008. PMID: 18294275 Free article.
Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer.
Maruyama R, Akino K, Toyota M, Suzuki H, Imai T, Ohe-Toyota M, Yamamoto E, Nojima M, Fujikane T, Sasaki Y, Yamashita T, Watanabe Y, Hiratsuka H, Hirata K, Itoh F, Imai K, Shinomura Y, Tokino T. Maruyama R, et al. Carcinogenesis. 2008 Jul;29(7):1312-8. doi: 10.1093/carcin/bgn060. Epub 2008 Feb 29. Carcinogenesis. 2008. PMID: 18310659 Free PMC article.
710 results